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Edited by Varda RotterAbstract We have recently shown that skin lesions of the
autoimmune disease pemphigus vulgaris are associated with Fas-
mediated apoptosis. Here, we describe the induction of the Fas-
dependent apoptosis pathway in cultured keratinocytes by
pemphigus vulgaris autoantibodies (PV-IgG), as seen from a
variety of cellular, morphological and biochemical parameters.
All apoptotic characters appear stronger and faster in aged
cultures than in young, showing increased susceptibility of
senescent keratinocytes to PV-IgG-mediated apoptotic death
and culture lesions. Together with immunosenescence, this
phenomenon may explain the late onset of pemphigus disease.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Replicative senescence1. Introduction
Skin ageing is characterized by various cellular and mor-
phological changes [1,2] that come with functional impair-
ments such as slow wound healing [3], decreased protection
against ultraviolet radiations [4], and increased susceptibility
to skin cancer [5]. Most of these alterations can be related to
skin senescence, which entails among others: reduced prolif-
eration [3], increased oxidative stress [6] and reduced DNA
repair capacity [7]. Cellular senescence can be induced in cul-
tures by serial passaging or by oxidative stress, and these two
kinds of models have been widely used to analyze the mech-
anisms of cellular ageing [8,9].
Programmed cell death (apoptosis) occurs in vivo for the
needs of tissue turnover or elimination [10] and it contributes
to anti-tumor protection, as does also cellular senescence
[11,12]. These two processes are, in fact, associated in normal
and pathological ageing [9,13] and their pathways overlap [14],
suggesting that apoptosis might be associated to the senescent
process itself. Yet, spontaneous apoptosis is not more frequent
in senescent cultures than in young [15]. On the contrary,
senescent human ﬁbroblasts and keratinocytes were found to* Corresponding author. Fax: +972-2658-5428.
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doi:10.1016/j.febslet.2004.04.083resist intrinsic [18] apoptosis induced by growth factor star-
vation [16] and ultraviolet irradiation [17], respectively. When
the extrinsic pathway [18] of apoptosis was induced, however,
senescent ﬁbroblasts [19–21] and senescent keratinocytes [22]
were found competent to apoptosis, and even more susceptible
than their young counterparts. We previously showed that
autoimmune antibodies from pemphigus vulgaris patients (PV-
IgG) can induce the Fas-dependent pathway of apoptosis in
human keratinocytes [23]. This was not really expected, since
PV-IgG recognize mainly adherent junctional proteins (desm-
ogleins 1 and 3) [24]. In this work, we show that cellular se-
nescence enhances PV-IgG-induced apoptosis in human
keratinocytes, providing further evidence that pemphigus le-
sional process may be driven by PV-IgG-induced apoptosis as
we proposed before [23], and that aged epidermal cells may be
more sensitive to it.2. Materials and methods
2.1. Antibodies and reagents
Anti-Bcl-2 polyclonal, anti-Fas L polyclonal, anti-caspase 8 poly-
clonal and anti-p53 (DO-1) monoclonal antibodies were from Santa
Cruz. Anti-Fas monoclonal was from Pharmingen, anti-involucrin
monoclonal from Sigma, anti-Ki 67 monoclonal from Dako and anti-
p16 monoclonal from Serotec. Enzyme-conjugated secondary anti-
bodies were from Sigma (alkaline phosphatase) or Kirkegaard & Perry
(peroxidase). FITC-conjugated goat anti-mouse, rhodamine red-
conjugated goat anti-mouse and R-phytoerythrin-conjugated donkey
anti-rabbit antibodies were from Jackson Immuno Research. Pem-
phigus-IgG (PV-IgG) was puriﬁed from patients’ sera as previously
described [23], Caspase substrates and inhibitors were from Calbio-
chem. The TUNEL apoptosis kit, propidium iodide and recombinant
human interferon-c (IFNc) were from Promega.
2.2. Keratinocyte cultures
Primary keratinocyte cultures were obtained by trypsinization of
newborn foreskins. Released cells were seeded and cultivated as pre-
viously described [22].
2.3. Biomarker diagnostic of cellular senescence in keratinocyte cultures
Keratinocyte suspensions were obtained from culture ﬂasks by
trypsinization and resuspension in PBS. Cell size was measured mi-
croscopically in a hemacytometer. Intrinsic ﬂuorescence was analyzed
at 480/560 nm by ﬂow cytometry. Total protein content was deter-
mined as described [25]. Other markers were characterized by immu-
noﬂuorescent labeling and ﬂow-cytometric analysis, as follows.
Suspended cells were ﬁxed 15 min at 30 C in PBS, 2% paraformal-
dehyde followed by cold methanol (67% ﬁnal, 1 h at 4 C). Cells were
washed twice in PBS and incubated 2 h at 30 C with the ﬁrst (antigen-
speciﬁc) antibody. They were washed twice in PBS and incubated 1 h
at 30 C with the second, FITC-labeled antibody. After two moreation of European Biochemical Societies.
Table 1
Enhancement of senescence markers in aged keratinocyte cultures
Biomarker Relative increase
SA b-galactosidase 2.5 0.2
P16 2.1 0.5
Protein content per cell 2.0 0.4
Intrinsic ﬂuorescence at 480/560 nm 2.0 0.2
Average cell size 1.6 0.3
Involucrin 1.1 0.1
Ki 67 0.6 0.1
Relative increase is the ratio of parameters determined in kerantino-
cytes at passage 4 versus passage 2. Speciﬁc markers were determined
by immunoﬂuorescent labeling and ﬂow cytometric analysis as de-
scribed in Section 2. Intrinsic ﬂuorescence at 480/560 nm measures the
age-related accumulation of lipofuscin in cells [31].
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cytometer and the average ﬂuorescent signal was determined.
2.4. DNA fragmentation assay
Keratinocytes were scraped oﬀ from culture plates, suspended in 100
mM NaCl, 1 mM EDTA, 10 mM Tris, pH 7.5, and incubated with 100
lg/ml proteinase K, 100 mM NaCl, 10 mM EDTA, 0.5% SDS, 10 mM
Tris, pH 7.5, for 1 h at 50 C. Lysates were subjected to phenol–
chloroform (1:1) extraction and ethanol-precipitated. Pellets were
dissolved in 1 mM EDTA and 10 mM Tris, pH 8.0, incubated for 1.5
min at 37 C with 20 lg/ml DNAse-free RNAse, and analyzed by
agarose gel electrophoresis.
2.5. Dot blots
Small drops (10 ll) of culture supernatants were spotted onto ni-
trocellulose paper. Blots were blocked in 10% milk in PBS, and incu-
bated with a speciﬁc antibody in 5% milk, 0.1% Tween 20, 150 nM
NaCl, and 50 mM Tris–HCl, pH 7.5, for 14 h at 4 C. After serial
washes, they were incubated with an alkaline phosphatase-conjugated,
secondary antibody for 2 h at room temperature, washed again, and
incubated with 5-bromo-4-chloro-3-indolyl phosphate and nitro blue
tetrazolium in 0.1 M NaCl, 50 mM MgCl2, and 0.1 M Tris–HCl, pH
9.2. Staining densities were analyzed using a ScanJet II CX/T gel
scanner with the NIH Image V1.61 program.
2.6. Cellular ELISA
Cultured keratinocytes were detached in a trypsin–EDTA solution,
washed and resuspended in PBS. Suspended cells were ﬁxed 15 min at
room temperature in 3% PFA, washed in PBS and counted in a he-
matocytometer. Samples of 5 105 cells were incubated 15 min with
0.1 M glycine, pH 7.5, and further permeabilized by 1% Triton X-100
in PBS, 30 min at room temperature. The cells were pelleted, washed,
and pretreated 10 min in 3% H2O2. After serial washes, cell suspen-
sions were incubated 1 h at room temperature in 5% BSA/PBS, then
overnight at 4 C with the ﬁrst antibody, in the same buﬀer with 0.05%
NaN3. After serial washes in 0.05% Tween/PBS, cells were incubated
with a second, peroxidase-conjugated antibody in 3% BSA/PBS, for 2
h at room temperature. After washings in 0.05% Tween, the pellet was
resuspended and immobilized enzyme conjugates were revealed by a
chromogenic substrate. Cell numbers were estimated by methylene
blue staining as described elsewhere [26].
2.7. Caspase assay
The method was adapted from published procedures [27,28]. Ke-
ratinocytes were detached and resuspended as above. The suspension
was homogenized in a Dounce homogenizer in 42 mM KCl, 1 mM
dithiothreitol, 5 mM EGTA, 1 lg/ml leupeptin, 1 lg/ml pepstatin and
0.1 mg/ml BSA in 10 mM HEPES, pH 7.4, and submitted to com-
plementary sonication. Protein concentration, evaluated by Bradford
determination, was brought to 5–10 mg/ml in homogenization buﬀer.
Enzyme activities were measured in samples containing 50 lg protein,
1 lM N-acetyl-Tyr–Val–Ala–Asp-amino-methyl-coumarin (N-Ac-
YVAD-AMC) (caspase 1), or 1 lM N-acetyl-Asp–Glu–Val–Asp-am-
nio-methyl-coumarin (N-Ac-DEVD-AMC) (caspase 3), in extraction
buﬀer and in 100 ll ﬁnal volume. For speciﬁcity controls, 1 lM caspase
1 inhibitor N-acetyl-Tyr–Val–Ala–Asp-CHO (N-Ac-YVAD-CHO) or
1 lM caspase 3 inhibitor N-acetyl-Asp–Glu–Val–Asp-CHO (N-Ac-
DEVD-CHO) was added. Released amino-methyl-coumarin was
monitored at 20 C, using 360 and 460 nm as excitation and emission
wavelengths, respectively.Fig. 1. Replicative senescence increases keratinocyte sensitivity to cell
death. (A) Keratinocytes were grown to conﬂuency after two passages
(young cells) or four passages (aged cells) and incubated ﬁve days with
1.5 lg/ml monoclonal anti-Fas+ 10 ng/ml IFNc, or with 2.5 g/ml PV-
IgG, or with 50 lg/ml CHX, or with 4 mg/ml N-IgG as control.
Boundaries of in vitro ‘‘lesions’’ are pointed by arrows. Magniﬁcation
200. (B) After three days of PV-IgG treatment, dead cells were
counted by trypan blue staining. Dead cell ratios in aged cultures were
averaged from four independent experiments, taking the values for
their young counterparts as 100%. (C) Percentages of dead cells were
measured by trypan blue staining at various times in young and aged
cultures.3. Results
3.1. Cell death and cell detachment, induced by PV-IgG or by
Fas pathway inducers, are enhanced in aged keratinocytes
Keratinocytes from newborn foreskins were grown to con-
ﬂuence after 1–2 passages (young cells) or 4–5 passages (aged
cells) as described in Section 2. The validity of passage 4 cells
as senescent was conﬁrmed by poor plating eﬃciency and
quasi-absence of proliferation upon attempts of further pas-saging. Senescence-related markers were checked as shown in
Table 1. Senescence-associated (SA) b-galactosidase [29], p16
[30], protein content per cell [26] and intrinsic ﬂuorescence
related to lipofuscin accumulation [31] were signiﬁcantly in-
creased, while the proliferation marker Ki 67 [32] was de-
creased, and the keratinocyte early diﬀerentiation marker
involucrin [33] remained unchanged, a pattern clearly featuring
replicative senescence. The young and aged cultures were in-
cubated with 1.5 lg/ml of Fas receptor-speciﬁc monoclonal
antibody (anti-Fas) combined with 10 ng/ml of IFNc, or with
2.5 mg/ml of immunoglobulins from pemphigus vulgaris pa-
tients (PV-IgG), or with 50 lg/ml of cycloheximide (CHX), a
control inducer activating the Fas-dependent pathway of ap-
optosis [34]. After 5 days, the three treatments caused cell
Fig. 2. Induction of apoptotic appearance in cultured keratinocytes.
Human keratinocytes were grown and treated as in Fig. 1A. (A) DNA
was extracted and 2 lg of DNA samples was electrophoresed on
agarose gels. (B) This phase-contrast micrography shows typical ap-
optotic characteristics induced by anti-Fas antibody in aged kerati-
nocytes. Magniﬁcation 1000.
Fig. 3. Fas L induction by PV-IgG is enhanced in aged keratinocytes.
Young (passage 2) and aged (passage 4) keratinocytes were grown to
conﬂuence in 24-well plates and treated by PV-IgG as above. Soluble
and membranal forms of Fas L were monitored by speciﬁc antibody
binding. (A) and (B) s-Fas L was detected in dot blots of growth
medium as described in Section 2. Relative staining was measured by
densitometry and plotted versus time of treatment. (C) and (D) m-Fas
L amounts were determined by cellular ELISA. In this ﬁgure, solid
symbols stand for treated cells and open symbols for controls treated
with 4 mg/ml N-IgG.
Fig. 4. Caspase induction by PV-IgG is enhanced in aged keratino-
cytes. Young and aged keratinocytes were grown to conﬂuence and
treated by PV-IgG as above. (A) and (B) Amounts of caspase 8 protein
were determined by cellular ELISA. Caspase 1 (C, D) and caspase 3
(E, F) were assayed in cellular extracts using ﬂuorogenic substrates as
described in Section 2. 100% activity represent 76.7 RFU/h for caspase
1 and 104 RFU/h for caspase 3. Solid symbols stand for treated cells
and open symbols for uninduced controls treated with 4 mg/ml N-IgG.
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and more abundant in aged cultures than in young. Such le-
sions were absent in untreated cultures, or in cultures treated
by IFNc alone, or by immunoglobulins from healthy donors
(Fig. 1A). Dead cells were counted in situ after 3 days (i.e.,
before lesion formation) using trypan blue vital staining. There
were 1.5 to 2 times more dead cells in aged cultures than in
young, depending on the inducer (Fig. 1B). No cell killing was
observed in control samples, treated with 4 mg/ml IgG from
healthy donors (N-IgG). Furthermore, kinetic measurements
showed that cell death induction by PV-IgG was faster in aged
cultures (Fig. 1C), in accordance with the observation that
inducers of Fas-mediated apoptosis kill aged cells more readily
[22].
3.2. DNA fragmentation and morphological changes, induced
by PV-IgG or by Fas pathway inducers in keratinocytes,
are enhanced in aged cells
Keratinocyte cultures were treated as above, DNA was ex-
tracted, and analyzed by electrophoresis. DNA fragmentation
and characteristic 190 bp ladders appeared in aged cell extracts
treated with either of the three inducers, but not in young cells,
and not in untreated controls (Fig. 2A). Under microscope,
trypan blue revealed more dead cells in aged cultures, as well as
cleared areas consecutive to cell detachment, surrounded by
morphologically altered cells (Fig. 2B) and typical apoptotic
features, like blebbing membranes (small white arrowheads) or
apoptotic bodies (large white arrowhead).
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accelerated in aged cells
Fas L is the natural activator of Fas receptor, found either
as a type-II transmembrane protein (m-Fas L), or as a soluble,
proteolytically derived fragment (s-Fas L). Both forms have
been ascribed the capacity to induce apoptosis [35]. We made
kinetic measurements of Fas L appearance, following PV-IgG
treatment, in cellular bodies and in cell supernatant, assaying
s-Fas L by dot blots and m-Fas L by cellular ELISA. s-Fas L
concentration increased 5-fold after 5 h of treatment in aged
keratinocyte cultures (Fig. 3A), whereas the same increase
took 50 h in young cultures (Fig. 3B). In parallel, m-Fas L
ELISA signals were increased 3.2-fold after 17 h in aged cul-
tures (Fig. 3C) and only 1.7-fold after 30 h in young cultures
(Fig. 3D).
3.4. PV-IgG-mediated caspase induction is accelerated and
ampliﬁed in aged keratinocytes
Caspases are a group of cystein proteases involved in dif-
ferent apoptotic steps. Caspases 8 and 10 activate the extrinsic
death pathway, and caspase 9 activates the intrinsic, mito-
chondrial pathway [18], while caspase 1 works mainly as a
cytokine precursor activator, and caspase 3 as an executor of
apoptosis [36], We measured the amounts of caspase 8 by
cellular ELISA at diﬀerent times, in keratinocyte cultures un-Fig. 5. Regulation ofBcl-2 and p53 by PV-IgG is enhanced in aged
keratinocytes. Young and old keratinocytes were grown to conﬂuence
and treated by PV-IgG as above for 3 days. Amounts of Bcl-2 and p53
proteins were determined by cellular ELISA in four independent ex-
periments. In each experiment, 100% corresponded to the untreated
control.der PV-IgG treatment The increase in caspase 8 was 2-fold
larger and 2-fold faster in aged cells than in young (Fig. 4A
and B), and consistently caspase 1 and caspase 3 activities
increased more in aged cell than in young cell lysates (Fig. 4C–
F). This showed that the apoptotic process was induced in its
diﬀerent stages and to a larger extent in aged keratinocytes.
3.5. PV-IgG-mediated induction of intrinsic apoptosis is
enhanced in aged keratinocytes
We investigated the fate of Bcl-2 and p53, two proteins in-
volved in the mitochondrial pathway of apoptosis as protective
and inducing eﬀector, respectively [18], Aged and young ke-
ratinocyte cultures were treated for 3 days with anti-Fas an-
tibody, PV-IgG or CHX [34]. Using cellular ELISA, we
observed that Bcl-2 was down-regulated and p53 was up-reg-
ulated, in accordance with their respective roles in the apop-
totic process. Consistently, this eﬀect was enhanced in aged
cells by the three apoptosis inducers used (Fig. 5).
3.6. Aged keratinocytes are resistant to protection against
apoptotic death
Apoptosis can be inhibited by speciﬁc reagents that prevent
its activation steps or inhibit its eﬀector enzymes. Caspase 1
inhibitor YVAD-CHO inhibits cell death in diﬀerent cell types
[37,38], and anti-FasL antibodies prevent Fas-mediated ap-
optosis in vivo and in vitro [39]. Keratinocytes were treated 4
days with anti-Fas or PV-IgG, in the presence or in the absence
of caspase 1 inhibitor. Fig. 6A and B compares death scores
observed in young and aged keratinocytes treated by anti-Fas
or by PV-IgG, taking the scores of uninduced controls as
100%. In aged cells, the level of dead cells was higher, andFig. 6. Apoptotic death is more diﬃcult to suppress in aged cells. (A)
and (B) Young and aged keratinocytes were grown to conﬂuence and
treated by monoclonal anti-Fas or by PV-IgG as above for 4 days, with
various concentrations of caspase 1 inhibitor. Death ratios were de-
termined by trypan blue staining. Control values obtained in the ab-
sence of treatment (for anti-Fas) or in the presence of 4 mg/ml N-IgG
(for PV-IgG) were taken as 100%. Solid symbols stand for aged cells
and open symbols for young cells. (C) and (D) Cells were incubated
with monoclonal anti-Fas in the presence or in the absence of anti-Fas
L antibodies. Death ratios were measured in four independent experi-
ments. In each experiment, the value obtained without anti-Fas L was
taken as 100%.
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caspase 1 inhibitor, showing that the inhibitor was poorly
protective. Then, keratinocyte cultures were treated with 1.5
lg/ml anti-Fas and 4 lg/ml anti-Fas L antibodies for four
days. The death scores were 74 6% in aged cells and 44 4%
in young cells, taking controls without anti-Fas L as 100%
(Fig. 6C and D). These results show that aged cells are not
only more prone to apoptotic death, but their apoptotic course
is also more diﬃcult to suppress.4. Discussion
The apoptotic equilibrium is known to be altered in a
variety of aged tissues. Excessive apoptosis is associated with
functional decline in aged heart, liver, kidney, immune sys-
tem and brain [40], and with neurodegenerative and auto-
immune diseases [41]. Balance between proliferation and
apoptosis is lost in the development of tumors [41], an age-
dependent phenomenon. Finally, oncogenes and cell cycle
regulators contribute to the apoptotic pathway [42,43], sug-
gesting that apoptosis may be linked to tumorigenesis and
cellular senescence.
First attempts to induce apoptosis in aged cells suggested
that human ﬁbroblasts [16] and keratinocytes [15,17] were re-
sistant to apoptosis at senescence. In all these experiments,
however, the inducing stimuli (growth factor deprivation,
calcium shock, UV irradiation) activated the intrinsic pathway
of apoptosis, mediated via the mitochondrial system [18].
When the extrinsic, cell signaling-mediated pathway was ad-
dressed, senescent cells were found competent for, and even
sensitized to, apoptosis induction, both in human ﬁbroblasts
[21] and in keratinocytes [22]. These data restored consistency
with in vivo evidence that Fas-mediated apoptosis is enhanced
in age-related disorders [13,41,44], as well as in normal ageing
[45].
We previously showed that autoimmune PV-IgG can in-
duce apoptosis in human keratinocytes [23]. In this work, we
compared this eﬀect in young and aged cell cultures, where
senescence of aged samples was characterized using biomar-
kers of cellular senescence and diﬀerentiation. Replicative
senescence increased keratinocyte propensity to apoptose,
upon PV-IgG as upon anti-Fas treatment, and the two in-
ducers caused similar symptoms. Hence, we can conclude
that PV-IgG activates the extrinsic apoptosis pathway, the
putative cause of the lesional process in pemphigus [23],
more readily in senescent cells. This ﬁnding is consistent with
our previous observation that senescent keratinocytes are
more sensitive to Fas-mediated apoptosis [22]. It is note-
worthy that p53 and Bcl-2, two participants of the intrinsic
apoptosis pathway, were also mobilized in the PV-IgG-
induced process, possibly because they contributed to a
mitochondrial ampliﬁcation loop [18] secondary to activation
of the Fas pathway.
A wealth of data convincingly suggests that cellular senes-
cence is associated with, and involved in, organismal ageing
[9]. Senescence markers are overexpressed in aged tissues [29].
Fibroblasts from old donors [46], or from patients with pre-
mature ageing syndromes [47], or from donors submitted to
photoageing [48], have a shorter life span when transplanted in
vitro. Mutations that enhance cellular senescence cause pre-
mature ageing and early death in engineered mice [49,50]. Wetherefore speculate that increased cellular senescence in aged
epidermis, and higher susceptibility of senescent cells to
PV-IgG-induced apoptosis, may be a cause of the increased
frequency and severity of pemphigus disease observed in the
elderly [51], on top of immunosenescence that enhances au-
toimmunity [52]. Furthermore, the fact that senescent cells are
more sensitive to the extrinsic apoptosis pathway turns out to
be a properly shared by diﬀerent cell types [21,22]. Since many
degenerative and autoimmune pathologies seem to proceed via
a Fas-mediated apoptotic pathway [13,41,44], age-relatedness
of these diseases may also be attributed to the increased sen-
sitivity of senescent cells to cell signaling-induced apoptosis.
This highlights the perspective that regulators of extrinsic ap-
optosis may be used to control these disorders, not only for the
treatment of acute symptoms, but also to address the more
general propensity of aged tissues to apoptose upon stimula-
tion by external signals, which may be a cause for many age-
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